These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 15026412)
21. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells. Li Q; Dashwood RH J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612 [TBL] [Abstract][Full Text] [Related]
22. The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis. Vleminckx K; Kemler R; Hecht A Mech Dev; 1999 Mar; 81(1-2):65-74. PubMed ID: 10330485 [TBL] [Abstract][Full Text] [Related]
23. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Eastman Q; Grosschedl R Curr Opin Cell Biol; 1999 Apr; 11(2):233-40. PubMed ID: 10209158 [TBL] [Abstract][Full Text] [Related]
24. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter. Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155 [TBL] [Abstract][Full Text] [Related]
25. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Gustavson MD; Crawford HC; Fingleton B; Matrisian LM Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508 [TBL] [Abstract][Full Text] [Related]
26. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control. Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878 [TBL] [Abstract][Full Text] [Related]
27. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Staal FJ; Meeldijk J; Moerer P; Jay P; van de Weerdt BC; Vainio S; Nolan GP; Clevers H Eur J Immunol; 2001 Jan; 31(1):285-93. PubMed ID: 11265645 [TBL] [Abstract][Full Text] [Related]
28. A new beta-catenin-dependent activation domain in T cell factor. Atcha FA; Munguia JE; Li TW; Hovanes K; Waterman ML J Biol Chem; 2003 May; 278(18):16169-75. PubMed ID: 12582159 [TBL] [Abstract][Full Text] [Related]
29. Beta-catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts. Young CS; Masckauchan TN; Kitajewski J Differentiation; 2003 Oct; 71(8):477-85. PubMed ID: 14641328 [TBL] [Abstract][Full Text] [Related]
30. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma. Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435 [TBL] [Abstract][Full Text] [Related]
31. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development. Schmidt M; Patterson M; Farrell E; Münsterberg A Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726 [TBL] [Abstract][Full Text] [Related]
32. Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Young CS; Kitamura M; Hardy S; Kitajewski J Mol Cell Biol; 1998 May; 18(5):2474-85. PubMed ID: 9566868 [TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. Letamendia A; Labbé E; Attisano L J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S31-9. PubMed ID: 11263663 [TBL] [Abstract][Full Text] [Related]
34. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Wang X; Xiao Y; Mou Y; Zhao Y; Blankesteijn WM; Hall JL Circ Res; 2002 Feb; 90(3):340-7. PubMed ID: 11861424 [TBL] [Abstract][Full Text] [Related]
35. Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas. Dorfman DM; Greisman HA; Shahsafaei A Am J Pathol; 2003 May; 162(5):1539-44. PubMed ID: 12707037 [TBL] [Abstract][Full Text] [Related]
36. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893 [TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. Smith E; Frenkel B J Biol Chem; 2005 Jan; 280(3):2388-94. PubMed ID: 15537647 [TBL] [Abstract][Full Text] [Related]
38. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. Ghogomu SM; van Venrooy S; Ritthaler M; Wedlich D; Gradl D J Biol Chem; 2006 Jan; 281(3):1755-64. PubMed ID: 16291758 [TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]